Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sven van Egmond"'
Autor:
Lotty Hooft, Pauline Heus, Gert P Westert, Rudolf B Kool, Suzanne E Geerlings, Janwillem Kocks, Prabath W B Nanayakkara, Tessa Rietbergen, Leti van Bodegom-Vos, Simone A van Dulmen, Eva W Verkerk, Corina de Jong, Bart J Laan, JOOST P H DRENTH, Marlies Wakkee, Aniek de Coninck, Harry C Schouten, Evelien I T de Schepper, Saskia F van Vugt, Renuka S Bindraban, Sven van Egmond, Judith J de Jong
Publikováno v:
BMJ Open Quality, Vol 11, Iss 3 (2022)
Background Reducing the overuse of care that is proven to be of low value increases the quality and safety of care. We aimed to identify lessons for reducing low-value care by looking at: (1) The effects of eight de-implementation projects. (2) The b
Externí odkaz:
https://doaj.org/article/765a305c91e64bc9b65399547acc336e
Autor:
Sven van Egmond, Ella D. van Vliet, Marlies Wakkee, Loes M. Hollestein, Xavier G. L. V. Pouwels, Hendrik Koffijberg, Yesim Misirli, Rachel S. L. A. Bakkum, Maarten T. Bastiaens, Nicole A. Kukutsch, Albert J. Oosting, Elsemieke I. Plasmeijer, Annik van Rengen, Kees-Peter de Roos, Tamar E. C. Nijsten, Esther de Vries, Esther W. de Bekker-Grob
Publikováno v:
PLoS ONE, Vol 17, Iss 1 (2022)
Background The incidence of keratinocyte carcinomas is high and rapidly growing. Approximately 80% of keratinocyte carcinomas consist of basal cell carcinomas (BCC) with 50% of these being considered as low-risk tumors. Nevertheless, 83% of the low-r
Externí odkaz:
https://doaj.org/article/a97150c00b824caa860b23403afd8990
Autor:
Sven van Egmond, Esther de Vries, Loes Hollestein, Maarten Bastiaens, Kees-Peter de Roos, Daniëlle Kuijpers, Ewout Steyerberg, Marlies Wakkee, Klara Mosterd, Tamar Nijsten, Esther W de Bekker-Grob
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0249298 (2021)
BackgroundFollow-up after low-risk basal cell carcinoma (BCC) is being provided more frequently than recommended by guidelines. To design an acceptable strategy to successfully reduce this 'low-value' care, it is important to obtain insights into the
Externí odkaz:
https://doaj.org/article/95f6dc50bb374b7ba6de4c7db32ab464
Autor:
Linde E. M. de Wijs, Sven van Egmond, Arjan C. A. Devillers, Tamar Nijsten, DirkJan Hijnen, Marjolein Lugtenberg
Publikováno v:
Archives of Dermatological Research
Archives of Dermatological Research, 315(1), 75-83. Springer-Verlag
Archives of Dermatological Research, 315(1), 75-83. Springer-Verlag
To optimally tailor atopic dermatitis (AD) care to patients’ needs, especially considering the many emerging therapeutic options, insight into patients’ needs and preferences regarding AD care is needed. To explore patients’ needs and preferenc
Autor:
Sven van Egmond, Marlies Wakkee, Marc A.M. Mureau, Ida J. Korfage, M. Lugtenberg, Marit Hoogenraad
Publikováno v:
Archives of Dermatological Research, 314(1), 25-36. Springer-Verlag
Archives of Dermatological Research
Archives of Dermatological Research
To provide patient-centered care, it is essential to explore what patients consider important and to adjust care accordingly. This may specifically be relevant for patients with complex skin cancer, for whom the care process is often more complicated
Autor:
Carin A. Uyl-de Groot, Sven van Egmond, Loes M. Hollestein, Judith A van Erkelens, Tamar Nijsten, Marlies Wakkee
Publikováno v:
Dermatology, 237(6), 1000-1006. Karger
Background: Quality indicators are used to benchmark and subsequently improve quality of healthcare. However, defining good quality indicators and applying them to high-volume care such as skin cancer is not always feasible. Objectives: To determine
Autor:
Sven van Egmond, Isabella de Vere Hunt, Zhuo Ran Cai, Nada Rizk, Marlies Wakkee, Mary-Margaret Chren, Noah Goldfarb, Julia F Simard, Eleni Linos
Publikováno v:
The British journal of dermatology, 188(1), 136-137. Wiley-Blackwell Publishing Ltd
In this survey study of over 600 US dermatologists, identical clinical scenarios (10mm primary asymptomatic BCC) were presented except for randomly varied patient characteristics including age, life expectancy, and tumor location. Most dermatologists